Post
krisdom
IOLCP
IOL Chemicals and Pharmaceuticals Ltd
Chemicals are 40 percent of its portfolio. It hopes to launch more products in the segment.
It reported subdued earnings for the March-ended quarter. Its margins have fallen led by a weak performance by the pharma segment while the chemical segment drove the overall growth.
It is in a transition phase where both the chemicals and pharma product portfolio is growing but pharma will grow faster than the chemicals and that will drive a higher percentage of our sales going forward.
It delivered 30 percent margins in FY21 and will be close to that number in CFY as well.
Jun 8 10:53 AM
· View Votes
NSE:IOLCP price when posted: 661.95